Premium
Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole
Author(s) -
Saraçoğlu F,
Göl K,
Şahin Ï,
Türkkani B,
Atalay C,
Öztopçu C
Publication year - 1998
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/s0020-7292(98)00029-0
Subject(s) - ornidazole , metronidazole , medicine , bacterial vaginosis , vagina , vaginal disease , gastroenterology , gynecology , antibiotics , surgery , microbiology and biotechnology , biology
Objective: To evaluate the clinical efficacy and tolerance of oral or vaginal ornidazole, secnidazole and metronidazole or their combinations for treatment of bacterial vaginosis. Method: In an open, randomized, prospective study, 152 patients with bacterial vaginosis according to Amsel's criteria were included into the study. The patients were divided into eight groups: (1) oral ornidazole 2×500 mg/day for 5 days; (2) vaginal ornidazole 500 mg/day for 5 days; (3) oral and vaginal ornidazole for 5 days; (4) oral secnidazole 2 g in a single dose; (5) oral secnidazole 2 g in a single dose and vaginal ornidazole 500 mg/day for 5 days; (6) oral secnidazole 2 g in a single dose and vaginal metronidazole 2×500 mg/day for 7 days; (7) oral ornidazole 2×500 mg/day for 5 days and vaginal metronidazole 2×500 mg/day for 7 days; and (8) vaginal metronidazole 2×500 mg/day for 7 days. None of the partners received any treatment. Result: We found a 100% cure rate in both oral and vaginal ornidazole and oral secnidazole–vaginal metronidazole groups. Conclusion: Vaginal treatments including ornidazole and metronidazole are not as effective as both oral and vaginal drug combinations.